Pulmonary and Critical Care Medicine services at Yale New Haven Hospital are nationally and internationally recognized for providing advanced care for patients. Our medical teams offer inpatient and outpatient services to diagnose and treat a wide range of respiratory diseases and disorders, including asthma, lung cancer, interstitial lung disease, pulmonary fibrosis, cystic fibrosis, COPD, pulmonary vascular disease, tuberculosis and sleep-disordered breathing.
Through outpatient services at the Winchester Center for Lung Disease, we diagnose and treat a range of respiratory conditions. We provide inpatient Critical Care Services in our adult intensive care units (ICUs), which offer specialized care, treatment and monitoring of critically ill patients.
For patients with a pulmonary embolism (a blood clot that has traveled to the lungs), treatment may include a minimally invasive procedure of embolectomy or thrombolysis in which a Heart and Vascular Center (HVC) interventional radiologist inserts a catheter fitted with a suction device into a vein in the groin or neck. The physician guides the catheter to the lung artery clot and applies suction to remove the clot. Patients are initially evaluated by the HVC’s multidisciplinary Pulmonary Embolism Response Team (PERT), which includes pulmonologists and interventional radiologists. The team works together with the patient to develop a treatment plan.
Yale New Haven Hospital is the only hospital in Connecticut that can perform a curative surgical procedure -- pulmonary thromboendarterectomy -- for adults with chronic thromboembolic pulmonary hypertension (CTEPH), a potential complication from a pulmonary embolism. Yale New Haven Hospital has a Pulmonary Hypertension Association-accredited Pulmonary Hypertension Care Center.
YNHH is the first hospital in Connecticut to offer lung biopsy procedure to patients using the most advanced robotic-bronchoscopy technology. Procedures are performed by our highly experienced interventional pulmonologists and thoracic surgeons united in the goal to save lives by diagnosing and treating lung cancer as early as possible.
The Medical Intensive Care Unit (MICU) offers specialized care, treatment and monitoring of critically ill adult patients admitted with life-threatening disorders such as septic shock, acute respiratory distress syndrome, fulminant liver failure and multi-organ failure. The clinical condition of these patients requires physician expertise and specialized nursing and technology. The MICU is located on two floors of the North Pavilion, providing 40 MICU beds alongside 16 step-down beds.
At the Neurosurgical ICU (NICU), a team of neurologists, neurosurgeons, medical intensivists and staff members care for patients who have suffered stroke, traumatic brain and spine injury, subarachnoid hemorrhage, aneurysm, autoimmune and movement disorders (Parkinson's disease, multiple sclerosis, Gullian-Barre, etc.) and neurological disorders.
Doctors at the Yale Center for Asthma and Airways Disease (YCAAD) are offering a new treatment that shows promise for moderate to severe asthma. Bronchial thermoplasty uses radiofrequency energy to gently heat the airways and decrease the tissue in the lungs that is responsible for bronchoconstriction and asthma attacks.
Some COVID-19 patients are continuing to experience respiratory symptoms long after their initial recovery from this illness. The Recovery Program at the Winchester Chest Clinic is open to those patients who have persistent respiratory symptoms. For patients who fit specific criteria, they should consult their primary care physician for a referral to the program.
We provide inpatient Critical Care Services in our adult intensive care units (ICUs), which offer specialized care, treatment and monitoring of critically ill patients.
The Medical Intensive Care Unit (MICU) — regarded as one of the region's elite ICUs — cares for patients admitted with a wide variety of medical problems. The MICU offers specialized care, treatment and monitoring of critically ill adult patients admitted with a wide range of life-threatening disorders, such as septic shock, acute respiratory distress syndrome, fulminant liver failure and multi-organ failure. The clinical condition of these patients necessitates physician expertise and specialized nursing and technology found at Yale New Haven's MICU.
The MICU is located in a state-of-the-art facility on two floors of the new North Pavilion, providing 40 MICU beds alongside 16 step-down beds.
At the Neurosurgical ICU (NICU), a team of neurologists, neurosurgeons, medical intensivists and highly trained staff members care for patients who have suffered stroke, traumatic brain and spine injury, subarachnoid hemorrhage, aneurysm, autoimmune and movement disorders (Parkinson's disease, multiple sclerosis, Gullian-Barre, etc.) and neurological disorders. Patients in the unit are closely monitored for subtle neurological changes. The unit actively participates in stroke and brain tumor research. We also offer consultation to medical staff at other intensive care units.
In addition to patient care, the Yale New Haven Pulmonary and Critical Care Program is home to a rich tapestry of basic, clinical and translational research activities. Research faculty are all successful investigators in their own right, but also cooperate closely with their peers in both basic and clinical departments to pursue interdisciplinary projects.
The Program has a wide and varied research portfolio that extends from basic bench-focused studies of disease pathogenesis and target gene validation to human-based studies of clinical issues such as asthma, COPD, ILD, acute lung injury and pulmonary vascular disease. A unifying theme among the bench-focused investigators is the desire to elucidate the cellular and molecular events involved in lung injury and repair. The result has been an intense focus on immunology and molecular biology and the development of scientific approaches that are now used throughout the world.
Learn more about pulmonary & critical care medicine clinical research initiatives
